Skip to main content
. 2022 Dec 4;12(12):1666. doi: 10.3390/brainsci12121666

Table 2.

Statistical properties of the psychometric measures applied in the sample of 105 patients with schizophrenia and schizoaffective disorder.

Psychometric Measure N Mean SD
PAS childhood 98 1.38 1.22
PAS early adolescence 98 2.05 1.30
PAS late adolescence 92 2.96 1.44
PAS adulthood 80 3.13 1.70
PAS general 97 3.43 1.24
PANSS, positive symptoms 105 14.84 4.76
PANSS, negative symptoms 105 19.38 6.56
PANSS, general psychopathology 105 40.70 10.41
PANSS, total score 105 74.92 17.93
CGI-SCH, severity positive symptoms 105 3.30 1.37
CGI-SCH, severity negative symptoms 105 3.25 0.94
CGI-SCH, severity depressive symptoms 105 2.36 1.05
CGI-SCH, severity cognitive symptoms 105 3.29 1.12
CGI-SCH, global severity 105 3.60 0.96
PSP, total score 105 50.60 14.18
WHOQOL, physical health 101 12.91 2.71
WHOQOL, psychological 101 12.08 1.78
WHOQOL, social relationship 101 11.68 3.74
WHOQOL, environment 101 12.11 2.35
BACS, verbal memory 102 5.26 2.34
BACS, digit sequencing task (number of correct response) 102 12.71 6.23
BACS, digit sequencing task (longest sequence recalled correctly) 102 5.08 2.09
BACS, verbal fluency (category instances) 102 9.14 5.05
BACS, verbal fluency (controlled oral word association test) 102 16.25 7.93
BACS, attention, and speed of information processing (symbol coding) 101 24.16 15.03
BACS, executive functions, Tower of London 101 8.71 6.40
SWN, mental functioning 100 15.97 4.23
SWN, self-control 100 15.94 3.24
SWN, physical functioning 100 16.29 4.33
SWN, emotional regulation 100 16.22 3.67
SWN, social integration 100 15.95 3.53
SWN, total score 100 80.37 13.96

PANSS: positive and negative syndrome scale; BMI: body mass index; PAS: premorbid adjustment scale; CGI-SCH: clinical global impression—schizophrenia; PSP: personal and social performance scale: WHOQOL: the World Health Organization quality of life scale; BACS: brief assessment of cognition in schizophrenia; SWN: subjective well-being under neuroleptics.